Miraca Holdings Incorporated operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Miraca Holdings Incorporated with three other
pharmaceutical manufacturers in Asia:
Dr. Lal PathLabs Ltd
sales of 7.91 billion Indian Rupees [US$118.62 million]
(109.02 billion Japanese Yen [US$1.05 billion]
of which 95%
was Testing business), and
Falco Holdings Co Ltd
(48.73 billion Japanese Yen [US$469.24 million]
of which 59%
was Medical Test).
Miraca Holdings Incorporated reported sales of ¥211.74 billion (US$2.04 billion)
March of 2016.
increase of 3.5%
versus 2015, when the company's sales were ¥204.67 billion.
Sales at Miraca Holdings Incorporated have increased during each of the previous five years
(and since 2011, sales have increased a total of 28%).
Sales of Clinical Medical Check saw an increase
5.4% in 2016, from
¥43.46 billion to ¥45.79 billion.